Impact of renal impairment on dihydropyrimidine dehydrogenase (DPD) phenotyping

por Royer, B., Launay, M., Ciccolini, J., Derain, L., Parant, F., Thomas, F., Guitton, J.
Publicado 2023

Population pharmacokinetics of the humanised monoclonal antibody, HuHMFG1 (AS1402), derived from a phase I study on breast cancer

por Royer, B, Yin, W, Pegram, M, Ibrahim, N, Villanueva, C, Mir, D, Erlandsson, F, Pivot, X
Publicado 2010

Myelofibrosis-Associated Lymphoproliferative Disease: Retrospective Study of 16 Cases and Literature Review

por Etienne, A., Gruson, B., Chatelain, D., Garidi, R., Royer, B., Sevestre, H., Marolleau, J. P., Damaj, G.
Publicado 2009

Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer

por Bazan, F., Dobi, E., Royer, B., Curtit, E., Mansi, L., Menneveau, N., Paillard, M. J., Meynard, G., Villanueva, C., Pivot, X., Chaigneau, L.
Publicado 2019

Time from first seen in specialist care to surgery does not influence survival outcome in patients with upfront resected pancreatic adenocarcinoma

por Brugel, M., Bouché, O., Kianmanesh, R., Teuma, L., Tashkandi, A., Regimbeau, J. M., Pessaux, P., Royer, B., Rhaiem, R., Perrenot, C., Neuzillet, C., Piardi, T., Deguelte, S.
Publicado 2021

1721P Prolonged positive SARS-CoV-2 RT-PCR in cancer outpatients requires specific reorganization of cancer centres

por Aguinaga, L., Ursu, R., Legoff, J., Delauguerre, C., Nguyen, O., Harel, S., Royer, B., sebert, M., Jachiet, M., Lebbé, C., Bonnet, C., Brice, P., Fenaux, P., Plaud, B., Aparicio, T.
Publicado 2020

Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study

por Royer, B, Kalbacher, E, Onteniente, S, Jullien, V, Montange, D, Piedoux, S, Thiery-Vuillemin, A, Delroeux, D, Pili-Floury, S, Guardiola, E, Combe, M, Muret, P, Nerich, V, Heyd, B, Chauffert, B, Kantelip, J-P, Pivot, X
Publicado 2012

B01 VENETOCLAX TARGETED THERAPY in AL AMYLOIDOSIS PATIENTS: A RETROSPECTIVE ANALYSIS FROM THE FRENCH AMYLOIDOSIS NETWORK

por Roussel, M., Pirotte, M., Gounot, R., Queru, K., Rizzo, O., Royer, B., Harel, S., Desport, E., Huart, A., Niault, M., Karlin, L., Decaux, O., Chalopin, T., Carpentier, B., Macro, M., Vignon, M., Chalayer, E., Stoppa, AM., Bridoux, F., Jaccard, A.
Publicado 2023

P956: EMMY COHORT: MANAGEMENT OF NEWLY DIAGNOSED OR RELAPSED/ REFRACTORY MULTIPLE MYELOMA IN PATIENTS AGED OF 80 YEARS AND OVER

por Macro, M., Decaux, O., Perrot, A., Royer, B., Chretien, M., Belhadj, K., Mohty, M., Frenzel, L., Leleu, X., Dib, M., Allangba, O., Zunic, P., Botoc, I., Malfuson, J., Moreau, P., Garlantazec, R., Texier, N., Germain, R., Deal, C., Hulin, C.
Publicado 2022

P955: CARFILZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: THE REAL-LIFE EXPERIENCE OF EMMY

por Hulin, C., Macro, M., Perrot, A., Royer, B., Caillot, D., Belhadj, K., Frenzel, L., Benramdane, R., Demarquette, H., Bareau, B., Darre, S., Calmettes, C., Le Calloch, R., Bouketouche, M., Laribi, K., Texier, N., Willaime, M., Deal, C., Moreau, P., Decaux, O.
Publicado 2022